228 related articles for article (PubMed ID: 21402692)
1. CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET).
Mitra R; Guo Z; Milani M; Mesaros C; Rodriguez M; Nguyen J; Luo X; Clarke D; Lamba J; Schuetz E; Donner DB; Puli N; Falck JR; Capdevila J; Gupta K; Blair IA; Potter DA
J Biol Chem; 2011 May; 286(20):17543-59. PubMed ID: 21402692
[TBL] [Abstract][Full Text] [Related]
2. Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
Guo Z; Sevrioukova IF; Denisov IG; Zhang X; Chiu TL; Thomas DG; Hanse EA; Cuellar RAD; Grinkova YV; Langenfeld VW; Swedien DS; Stamschror JD; Alvarez J; Luna F; Galván A; Bae YK; Wulfkuhle JD; Gallagher RI; Petricoin EF; Norris B; Flory CM; Schumacher RJ; O'Sullivan MG; Cao Q; Chu H; Lipscomb JD; Atkins WM; Gupta K; Kelekar A; Blair IA; Capdevila JH; Falck JR; Sligar SG; Poulos TL; Georg GI; Ambrose E; Potter DA
Cell Chem Biol; 2017 Oct; 24(10):1259-1275.e6. PubMed ID: 28919040
[TBL] [Abstract][Full Text] [Related]
3. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor.
Chen JK; Wang DW; Falck JR; Capdevila J; Harris RC
J Biol Chem; 1999 Feb; 274(8):4764-9. PubMed ID: 9988714
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CYP3A4, but not of CYP2D6, promotes hypoxic response and cell growth of Hep3B cells.
Oguro A; Sakamoto K; Funae Y; Imaoka S
Drug Metab Pharmacokinet; 2011; 26(4):407-15. PubMed ID: 21566342
[TBL] [Abstract][Full Text] [Related]
5. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer.
Tang H; Kuang Y; Wu W; Peng B; Fu Q
Mol Med; 2023 Sep; 29(1):127. PubMed ID: 37710176
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
8. Recovery of Ca2+ pools and growth in Ca2+ pool-depleted cells is mediated by specific epoxyeicosatrienoic acids derived from arachidonic acid.
Graber MN; Alfonso A; Gill DL
J Biol Chem; 1997 Nov; 272(47):29546-53. PubMed ID: 9368016
[TBL] [Abstract][Full Text] [Related]
9. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
10. 14,15-EET induces the infiltration and tumor-promoting function of neutrophils to trigger the growth of minimal dormant metastases.
Luo J; Feng XX; Luo C; Wang Y; Li D; Shu Y; Wang SS; Qin J; Li YC; Zou JM; Tian DA; Zhang GM; Feng ZH
Oncotarget; 2016 Jul; 7(28):43324-43336. PubMed ID: 27270316
[TBL] [Abstract][Full Text] [Related]
11. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
Yan G; Chen S; You B; Sun J
Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
[TBL] [Abstract][Full Text] [Related]
12. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells.
Jiang JX; Zhang SJ; Liu YN; Lin XX; Sun YH; Shen HJ; Yan XF; Xie QM
Eur J Pharmacol; 2014 Mar; 727():43-51. PubMed ID: 24486707
[TBL] [Abstract][Full Text] [Related]
13. 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1.
Potente M; Fisslthaler B; Busse R; Fleming I
J Biol Chem; 2003 Aug; 278(32):29619-25. PubMed ID: 12773534
[TBL] [Abstract][Full Text] [Related]
14. Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them.
Guo Z; Johnson V; Barrera J; Porras M; Hinojosa D; Hernández I; McGarrah P; Potter DA
Cancer Metastasis Rev; 2018 Sep; 37(2-3):409-423. PubMed ID: 30066055
[TBL] [Abstract][Full Text] [Related]
15. EET signaling in cancer.
Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC
Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066
[TBL] [Abstract][Full Text] [Related]
16. An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis.
Cheranov SY; Karpurapu M; Wang D; Zhang B; Venema RC; Rao GN
Blood; 2008 Jun; 111(12):5581-91. PubMed ID: 18408167
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic acids (EETs) regulate epithelial sodium channel activity by extracellular signal-regulated kinase 1/2 (ERK1/2)-mediated phosphorylation.
Pidkovka N; Rao R; Mei S; Gong Y; Harris RC; Wang WH; Capdevila JH
J Biol Chem; 2013 Feb; 288(7):5223-31. PubMed ID: 23283969
[TBL] [Abstract][Full Text] [Related]
18. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
19. SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway.
Xing J; Li J; Fu L; Gai J; Guan J; Li Q
Cancer Med; 2019 Nov; 8(16):7086-7097. PubMed ID: 31573734
[TBL] [Abstract][Full Text] [Related]
20. 11,12-EET suppressed LPS induced TF expression and thrombus formation by accelerating mRNA degradation rate via strengthening PI3K-Akt signaling pathway and inhibiting p38-TTP pathway.
Luo L; Yang Y; Fu M; Luo J; Li W; Tu L; Dong R
Prostaglandins Other Lipid Mediat; 2023 Aug; 167():106740. PubMed ID: 37119935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
